{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:39:48Z","timestamp":1783575588364,"version":"3.55.0"},"reference-count":41,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T00:00:00Z","timestamp":1187568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aim: In a previous study we showed that metformin reduced BMI <jats:italic>z<\/jats:italic>\u2010scores and fasting glucose and insulin concentrations, and increased whole body insulin sensitivity in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. We analyzed the data from this study to determine (a) if metformin reduced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations during the 6\u2010month trial, and (b) if the response to pharmacotherapy varied along gender or ethnic lines.<\/jats:p><jats:p>Methods: The 6\u2010month trial was randomized, double blinded and placebo controlled; a total of 14 metformin\u2010treated (500 mg bid) and 15 placebo\u2010treated subjects completed the study. There were no dietary restrictions.<\/jats:p><jats:p>Results: In obese adolescents fed ad libitum, metformin (a) prevented the rise in ALT concentrations that were observed in placebo\u2010treated subjects at the 3 to 5 month time\u2010points (p &lt; 0.05); (b) reduced (p &lt; 0.01) the percentage of all ALT values exceeding 40 U\/L; and (c) caused a modest (10%) but statistically significant (p &lt; 0.05) reduction in serum ALT in Caucasian subjects. Metformin had no effect on ALT levels or the ALT to AST ratio in the five African American adolescents enrolled in the study but reduced their fasting insulin concentrations from 26.1 to 19.5 \u03bcU\/mL (p &lt; 0.05).<\/jats:p><jats:p>Conclusions: Our findings suggest that metformin might reduce the rates or severity of liver dysfunction in selected high\u2010risk adolescents.<\/jats:p>","DOI":"10.1111\/j.1651-2227.2007.00429.x","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T22:16:15Z","timestamp":1192659375000},"page":"1326-1332","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin"],"prefix":"10.1111","volume":"96","author":[{"given":"Michael","family":"Freemark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1997.tb08881.x"},{"key":"e_1_2_6_3_2","first-page":"801","article-title":"Social epidemiology of chronic liver disease and cirrhosis in the United States 1935\u20131997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption","volume":"72","author":"Singh GK","year":"2000","journal-title":"Hum Biol"},{"issue":"1","key":"e_1_2_6_4_2","first-page":"S17","article-title":"Pathophysiology of nonalcoholic steatohepatitis","volume":"40","author":"McCullough AJ","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20973"},{"issue":"1","key":"e_1_2_6_6_2","first-page":"S11","article-title":"Natural history of nonalcoholic steatohepatitis","volume":"40","author":"Liou I","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1832"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1212"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2006.tb02349.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1010"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602588"},{"key":"e_1_2_6_12_2","first-page":"S34","article-title":"Diagnostic evaluation of nonalcoholic fatty liver disease","volume":"40","author":"Adams LA","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20842"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.12.007"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mog.0000218961.86182.8c"},{"key":"e_1_2_6_16_2","first-page":"291","article-title":"Steatosis and hepatocellular carcinoma risk","volume":"9","author":"Smedile A","year":"2005","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0587"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2774"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.07.030"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.6.1889"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800571"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00449-2"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21262"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060326"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13505"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.8.2169"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02025.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01888.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41583.x"},{"issue":"1","key":"e_1_2_6_30_2","first-page":"S61","article-title":"Therapy of NAFLD: insulin sensitizing agents","volume":"40","author":"Caldwell SH","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.4.e55"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000177314.65824.4d"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04059.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07485.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-1-200207020-00006"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02420.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00304.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.064964"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1237"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000221429.94591.72"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000201938.78044.75"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.01.06.db05-0943"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2007.00429.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2007.00429.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T02:37:48Z","timestamp":1695955068000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2007.00429.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,20]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1651-2227.2007.00429.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2007.00429.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,20]]},"assertion":[{"value":"2007-08-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}